Hematology, Iron & Nutrient Panel

Navigation & Literature

• Parent Silo: 03 - Diagnostics & Quantified Self MOC
• Literature Dossier: Hematology, Iron & Nutrient Panel - References

---

1. Reference Range Comparison (Standard vs. Longevity Optimal)

Sub-Marker	Standard Clinical Range	Longevity / Functional Optimal	Primary Unit	Physiological Meaning
Ferritin	$30–400\text{ ng/mL}$ (M) / $15–150\text{ ng/mL}$ (F)	$50–100\text{ ng/mL}$ (avoid $>150\text{ ng/mL}$)	$\text{ng/mL}$	Intracellular iron storage protein (and acute-phase inflammatory reactant)
Transferrin Saturation (TSAT)	$15–50\%$	$25–35\%$	$\%$	$\text{Serum Iron}/\text{TIBC}\times 100$; circulating iron transport saturation
MCV (Mean Corpuscular Volume)	$80–100\text{ fL}$	$86–92\text{ fL}$	$\text{fL}$	Erythrocyte volume: $<84\text{ fL}$ iron/B6 deficit; $>94\text{ fL}$ folate/B12 deficit
RDW (Red Cell Distribution Width)	$11.5–14.5\%$	$<12.5\%$ (ideal $11.5–12.2\%$)	$\%$	Erythrocyte size variance (anisocytosis); potent hematologic aging & mortality proxy
RBC Magnesium	$4.2–6.8\text{ mg/dL}$ (Serum: $1.7–2.2$)	$5.5–6.5\text{ mg/dL}$	$\text{mg/dL}$	Intracellular ${\text{Mg}}^{2+}$ reserve (serum holds $<1\%$ of total body magnesium)
25-OH Vitamin D	$30–100\text{ ng/mL}$	$45–65\text{ ng/mL}$ ($112–162\text{ nmol/L}$)	$\text{ng/mL}$	Prohormone calcidiol substrate for endocrine and autocrine VDR signaling
Active B12 (Holotranscobalamin)	$>35\text{ pmol/L}$ (Serum B12: $200–900\text{ pg/mL}$)	$>70\text{ pmol/L}$ (Serum B12: $600–1000\text{ pg/mL}$)	$\text{pmol/L}$	Transcobalamin-II bound bioavailable B12 (validated with Methylmalonic Acid $<150\text{ nmol/L}$)
Serum / RBC Folate	$>4.0\text{ ng/mL}$	$15–25\text{ ng/mL}$ (RBC Folate $>500\text{ ng/mL}$)	$\text{ng/mL}$	One-carbon donor pool for DNA thymidylate synthesis and homocysteine remethylation
Omega-3 Index (RBC EPA+DHA)	$>4.0\%$	$8.0–12.0\%$	$\%$	Percentage of EPA + DHA in erythrocyte phospholipid membranes
Plasma Zinc : Serum Copper Ratio	Zn $60–120\mu \text{g/dL}$ / Cu $70–140\mu \text{g/dL}$	Ratio $1.0–1.2$ (Zn $90–115$ / Cu $80–105$)	$\mu \text{g/dL}$	Metallothionein balance, SOD1 antioxidant activity, and neurotransmitter cofactor ratio

---

2. Physiological Significance & Hazard Curves

The Iron Goldilocks Curve (Fenton Chemistry vs. Mitochondrial Cytochromes)

Iron is essential for hemoglobin oxygen transport, mitochondrial electron transport chain iron-sulfur ($\text{Fe-S}$) clusters, cytochrome P450 enzymes, tyrosine/tryptophan hydroxylase, and thyroid peroxidase.

• Deficiency ($\text{Ferritin}<35–40\text{ ng/mL}$ or $\text{TSAT}<20\%$): Causes non-anemic fatigue, restless legs syndrome (impaired striatal dopamine synthesis), impaired ${\text{VO}}_2\text{ max}$, hair shedding, and poor T4 $\to$ T3 conversion.
• Overload ($\text{Ferritin}>150–200\text{ ng/mL}$ or $\text{TSAT}>45\%$): Free labile iron catalyzes the Fenton reaction (${\text{Fe}}^{2+}+{\text{H}}_2{\text{O}}_2\to {\text{Fe}}^{3+}+{\text{OH}}^{\bullet }+{\text{OH}}^{-}$), generating hydroxyl radicals that drive ferroptosis, pancreatic $\beta$-cell damage, hepatic fibrosis, and accelerated biological aging. Because ferritin is also an acute-phase reactant, always interpret ferritin alongside hs-CRP and TSAT (high ferritin + low TSAT = anemia of chronic inflammation via hepcidin upregulation).

Red Cell Distribution Width (RDW) as an Integrative Aging Biomarker

RDW quantifies the coefficient of variation in circulating red blood cell volumes. In large population cohorts (NHANES, UK Biobank), RDW is one of the strongest routine hematologic predictors of all-cause mortality: each $1\%$ increase in RDW above $12.5\%$ confers a 14–23% increase in all-cause mortality hazard ($\text{HR }1.14–1.23$), even in non-anemic individuals. Elevated RDW reflects delayed erythropoietic maturation (B12/folate/iron insufficiency) or delayed senescent RBC splenic clearance driven by oxidative stress and inflammation.

Intracellular Micronutrients & Membrane Biophysics (Omega-3 Index, RBC Mg, Vitamin D)

• Omega-3 Index ($8–12\%$): Measures erythrocyte membrane EPA + DHA incorporation over 120 days. Compared to an Omega-3 Index $<4\%$, individuals at $\ge 8\%$ exhibit a 35% lower risk of all-cause mortality and up to 70–90% lower risk of sudden cardiac death due to membrane fluidity, anti-arrhythmic ion channel stabilization, and specialized pro-resolving mediator (resolvins/protectins) synthesis.
• RBC Magnesium vs. Serum Magnesium: Because extracellular serum magnesium ($1.7–2.2\text{ mg/dL}$) is tightly buffered at the expense of bone and intracellular stores, normal serum Mg masks widespread intracellular deficiency. RBC Magnesium ($5.5–6.5\text{ mg/dL}$) accurately reflects availability for $>600$ ATP-dependent enzymatic reactions (${\text{Mg-ATP}}^{2-}$).

---

3. Root Causes of Dysregulation

• Elevated Ferritin ($>150\text{ ng/mL}$): HFE gene variants (C282Y, H63D hereditary hemochromatosis), high red meat/heme iron intake in men and post-menopausal women lacking menstrual blood loss, or metabolic syndrome / MASLD (“dysmetabolic iron overload syndrome”).
• Low Ferritin ($<40\text{ ng/mL}$): Heavy menstrual bleeding, endurance running foot-strike hemolysis and GI micro-bleeding, low dietary heme iron or high phytate/tannin intake, Helicobacter pylori or celiac malabsorption, and PPI use (low gastric HCl impairs ${\text{Fe}}^{3+}\to {\text{Fe}}^{2+}$ reduction).
• Zinc/Copper Imbalance: High-dose zinc supplementation ($>40\text{ mg/day}$) without copper induces intestinal metallothionein, trapping copper and causing copper-deficiency neutropenia/neuropathy; conversely, estrogen/OCPs and copper pipes elevate serum copper and ceruloplasmin.

---

4. Actionable Interventions

Foundational Protocols (01 - Foundations)

• Therapeutic Phlebotomy / Blood Donation: For men and post-menopausal women with ferritin $>120–150\text{ ng/mL}$ (and normal hemoglobin), donating whole blood ($450\text{ mL}$) 1–3 times per year lowers ferritin by ~30–50 ng/mL per donation and improves insulin sensitivity and blood viscosity.
• Alternate-Day Iron Dosing (for Deficiency): Oral iron triggers a 24-hour hepatic hepcidin spike that blocks subsequent iron absorption. Taking iron bisglycinate ($25–50\text{ mg}$) with Vitamin C every other morning increases fractional absorption by 30–50% with minimal GI distress per Macronutrient & Micronutrient Optimization.

Molecular & Pharmacological Interventions (02 - Compounds & Molecules)

• Lipid Membrane Enrichment: Titrate triglyceride or phospholipid EPA/DHA ($2–4\text{ g/day}$) via Omega-3 & Lipid Membrane Health to reach an Omega-3 Index of $8–12\%$.
• Intracellular Magnesium Repletion: Combine Magnesium Glycinate ($200–300\text{ mg}$ evening) and Magnesium L-Threonate or Malate ($100–200\text{ mg}$ morning) via Magnesium Forms & Bioavailability.
• Vitamin D3 + K2 Stoichiometry: Supplement Vitamin D3 ($4,000–6,000\text{ IU/day}$) paired with Vitamin K2 (MK-7 $100–200\mu \text{g}$ + MK-4) via Vitamin D3, K2 & Calcium Homeostasis to maintain 25-OH Vitamin D at $45–65\text{ ng/mL}$ while directing calcium into bone matrix via osteocalcin carboxylation.
• Active B-Vitamins: Normalize MCV ($88–91\text{ fL}$) and Active B12 using methylcobalamin/adenosylcobalamin and 5-MTHF via Methylation & B-Complex.

---

5. Key Scientific Evidence Summary

• Harris et al. (2021, Nature Communications): FORCE Consortium pooled analysis of 17 prospective cohorts ($n=42,466$) demonstrating significant reductions in all-cause, cardiovascular, and cancer mortality in the top quintile of circulating EPA+DHA.
• Patel et al. (2009, Archives of Internal Medicine): NHANES III study ($n=8,175$) proving Red Cell Distribution Width (RDW) is a powerful dose-dependent predictor of all-cause mortality ($\text{HR }1.22$ per 1% RDW increment).
• Stoffel et al. (2017, Lancet Haematology): Isotope absorption trial proving alternate-day oral iron dosing outperforms consecutive-day dosing via hepcidin kinetics.

See full bibliographic details and quantitative effect sizes in Hematology, Iron & Nutrient Panel - References.